Pervin Hurmuz

8PUBLICATIONS
16CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 22, 2026
Factors influencing the use of hypofractionated radiotherapy in prostate cancer: a nationwide survey of radiation oncologists in Turkiye (TROD 09-008).

|Dec 16, 2025
Impact of Adjuvant Radiotherapy and Mitotane on Survival in Localized Adrenocortical Carcinoma: A Retrospective Cohort Study.

Aysenur Elmali, Ozan Cem Guler, Gokhan Ozyigit

|Feb 24, 2025
Translation, Cross-Cultural Adaptation, and Psychometric Validation of the Turkish Version of the "Expanded Prostate Cancer Index Composite (EPIC)" in Prostate Cancer Patients.

Burak Tilki, Pervin Hurmuz, Deniz Yuce

|Jan 11, 2025
Development of a Prognostic Nomogram for Overall Survival in Gastric Cancer Patients Who Underwent Adjuvant Chemoradiotherapy.

Melek Tugce Yilmaz, Pervin Hurmuz, Osman Dag

|Jan 10, 2025
Predicting acute and late toxicity in prostate cancer stereotactic ablative radiotherapy: the role of dosimetric parameters and prostate volume.

Gokhan Ozyigit, Pervin Hurmuz, Pantea Bayatfard

|Dec 06, 2024
Evaluating the impact of cardiac substructure dosimetric parameters on survival in lung cancer patients undergoing postoperative radiotherapy.

Melek Tugce Yilmaz, Pervin Hurmuz, Ezgi Gurlek

Pageof 2

Frequent Collaborators

4 joint publications

Gokhan Ozyigit

3 joint publications

Melek Tugce Yilmaz

2 joint publications

Caglayan Selenge Beduk Esen

2 joint publications

Faruk Zorlu